DNA testing companies are starting to profit from selling our data on to big pharma. Perhaps they should be paying us, says science writer Laura Spinney.
DNA testing companies are starting to profit from selling our data on to big pharma. Perhaps they should be paying us, says science writer Laura Spinney.
Comments are closed.